Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”

Detalles Bibliográficos
Autores principales: Bonny, Aimé, Talle, Mohammed A., Ngantcha, Marcus, Tayebjee, Muzahir H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462460/
https://www.ncbi.nlm.nih.gov/pubmed/32889105
http://dx.doi.org/10.1016/j.tmaid.2020.101861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462460/
https://www.ncbi.nlm.nih.gov/pubmed/32889105
http://dx.doi.org/10.1016/j.tmaid.2020.101861

Ejemplares similares